Six-year clinical and angiographic follow-up of patients with previously documented complete revascularization

E W Robert1, D F Guthaner, L Wexler

  • 1Cardiology Division, Stanford University Medical Center, Stanford, California 94305, USA.

Circulation
|September 1, 1978
PubMed

Insights

Late symptomatic deterioration after coronary bypass surgery is common. This often results from the progression of coronary artery disease, even with initially successful surgery and patent grafts.

Area of Science:

  • Cardiology
  • Vascular Surgery

Background:

  • Limited data exists on the long-term clinical and angiographic outcomes of patients following initially successful coronary artery bypass grafting (CABG).
  • Assessing late graft patency and disease progression is crucial for understanding long-term patient status.

Purpose of the Study:

  • To evaluate the late clinical and angiographic status of patients who underwent coronary bypass surgery with initially complete revascularization.
  • To investigate the relationship between graft patency, progression of coronary artery disease, and long-term symptoms.

Main Methods:

  • Follow-up angiography at 1 year and 6 years post-CABG in a cohort of 19 patients with complete revascularization.
  • Assessment of graft patency, luminal narrowing in native vessels, and patient symptom status (angina).

Main Results:

  • At 6 years, 86% of grafts remained patent.
  • 52% of patients showed significant atherosclerotic progression (> or = 70% luminal narrowing) in major vessels.
  • Late symptomatic deterioration (angina) was strongly associated with progression of coronary artery disease (88% of worsened patients) rather than graft failure.

Conclusions:

  • Symptomatic deterioration is common in the late phase after coronary bypass surgery.
  • Progression of underlying coronary artery disease, not graft failure, is the primary driver of late symptom recurrence.
  • Long-term management strategies should address the progression of native coronary artery disease.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...